Medical Health & Life Science Research News

France over the counter drugs market is expected to reach USD 4.73 billion by 2021 according to new research report

France over the counter drugs market is expected to reach USD 4.73 billion by 2021 according to new research report

France Over the Counter Drugs Market by Formulation Type (Liquids, Tablets, Ointments, Sprays), by Product Type (Analgesics, Antiseptics, Anti-Allergy Drugs, Cough, Cold and Flu Drugs, Dermatologics, Gastrointestinal drugs, Vitamins and Minerals, Weight Loss/Diet Drugs, Sleep Aids, Ophthalmics, Smoking Cession Aids and Other Products), by Distribution Channel (Pharmacies, Supermarkets/Hypermarkets, convenience stores, others) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

- Advertising -

France Over the Counter Drugs market is estimated to be USD 3.98 billion in 2016 and is projected to reach USD 4.73 billion by 2021 growing at a CAGR of 3.5% in the review period. Pharmacies are highly prevalent throughout the country and over the counter (OTC) drugs are considered safe and are widely used by significant population in France.

People are encouraged by the government to try non-prescriptive drugs before visiting a doctor to ease the pressure on the health service. Paracetamol, aspirin and ibuprofen are the most widely used OTC drugs in France.

- Advertising -

Browse Market data tables and in-depth TOC of the France Over the Counter Drugs Market to 2021 at www.marketdataforecast.com/market-…drugs-market-806/

Ease of access, convenience and low cost are driving the OTC market in France. When most of the countries are considering to restrict OTC sales of certain drugs, French authorities are moving in the opposite direction.

Liberalising the sales of OTC drugs is also likely to dampen the public’s expenditure on health and increase its sales. Increasing access to new channels, cultural shift of public towards self-medication are also fueling the growth of the market.

Online pharmacies are also being launched in France making the over the counter drugs more accessible.

However, non-availability of reimbursements through government insurance schemes is a major setback for the OTC drugs markets. The prices has also gone up in the last decade as a result of pharmacist’s monopoly on the retail segment.

These along with the issues pertaining to drug substance abuse are restraining the growth of the market.

Report: www.marketdataforecast.com/market-…06/request-sample

France OTC Drugs market is segmented based on the formulation type, product type and distribution channels. By the type of formulation, the market is segmented into tablets, liquids, ointments and sprays.

By product type, the OTC drugs are categorised into Cough, Cold and Flu Drugs, Analgesics, Dermatologics, Gastrointestinal Drugs, Antiseptics, Anti-Allergy Drugs, Smoking Cessation Aids, Ophthalmics, Vitamins and Minerals, Sleep Aids, Weight Loss/Diet Drugs and others. Based on the distribution channels, the market is segmented into Pharmacies/Drug Stores, Supermarkets/Hypermarkets, Convenience Stores and others.

The major companies in the OTC drugs industry include GlaxoSmithKline, Procter & Gamble, Reckitt Benckiser, Johnson and Johnson, Novartis, Bayer, Pfizer, Sanofi and Takeda

Report: www.marketdataforecast.com/market-…arket-806/inquire

 

News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...